N-methyl-D-aspartic acid, or N-methyl-D-aspartate, is an amino acid derivative that acts as a specific agonist at the NMDA receptor mimicking the action of glutamate, the neurotransmitter which normally acts at that receptor. From Wikipedia
Following cognitive improvement in mice, the therapy advances to safety testing ahead of first-in-human trials.
